论文信息 - Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST - 字舞流文

Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST

G. Demetri | M. Heinrich | P. Casali | I. Judson | M. Blackstein | C. Baum | G. McArthur | C. Garrett | M. Shah | A. Oosterom | M. Shah